| # | Drug | Count |
|---|---|---|
| 0 | OCRELIZUMAB | 10 |
| 1 | RITUXIMAB | 5 |
| 2 | BACLOFEN | 4 |
| 3 | METHYLPREDNISOLONE | 4 |
| 4 | ACETAMINOPHEN | 3 |
| 5 | ACETAMINOPHEN 500MG | 3 |
| 6 | ACETAMINOPHEN TABLET EXTENDED RELEASE | 3 |
| 7 | DIPHENHYDRAMINE | 3 |
| 8 | DIPHENHYDRAMINE HYDROCHLORIDE | 3 |
| 9 | PAIN RELIEVER | 3 |
| # | Drug | Count | Frequency |
|---|---|---|---|
| 0 | GLOFITAMAB | 1 | 0.0004 |
| 1 | UBLITUXIMAB | 1 | 0.0003 |
| 2 | SIPONIMOD | 2 | 0.0002 |
| 3 | OCRELIZUMAB | 10 | 0.0002 |
| 4 | TIZANIDINE HYDROCHLORIDE | 2 | 0.0001 |
| 5 | AXICABTAGENE CILOLEUCEL | 1 | 0.0001 |
| 6 | PREDNISOLONE ACETATE | 1 | 0.0001 |
| 7 | CLOTRIMAZOLE TOPICAL | 1 | 0.0001 |
| 8 | OXYCODONE HYDROCHLORIDE AND ACETAMINOPHEN | 1 | 0.0001 |
| 9 | CLOTRIMAZOLE | 1 | 0.0001 |
| # | Drug class | Count | Frequency |
|---|---|---|---|
| 0 | Bispecific CD20-directed CD3 T Cell Engager [EPC] | 1 | 0.0002 |
| 1 | Sphingosine 1-phosphate Receptor Modulator [EPC] | 2 | 0.0001 |
| 2 | CD19-directed Chimeric Antigen Receptor [EPC] | 1 | 0.0001 |
| 3 | CD20-directed Cytolytic Antibody [EPC] | 18 | 0.0001 |
| 4 | gamma-Aminobutyric Acid-ergic Agonist [EPC] | 4 | 0.0000 |
| 5 | Potassium Channel Blocker [EPC] | 2 | 0.0000 |
| 6 | Polyene Antifungal [EPC] | 1 | 0.0000 |
| 7 | Serotonin Reuptake Inhibitor [EPC] | 2 | 0.0000 |
| 8 | beta3-Adrenergic Agonist [EPC] | 1 | 0.0000 |
| 9 | Complement Inhibitor [EPC] | 1 | 0.0000 |